Execution On Expansion Plans Will Shape Near-Term Manufacturing Opportunities

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

04 Sep 24

Updated

10 Dec 25

Views

62

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-3.6%

7D

-4.1%

Loading

1Y

-3.6%

7D

-4.1%

You can edit this narrative until Dec 11 4:25 AM. Then, changes will post as Updates.

Author's Valuation

US$1593.6% undervalued

AnalystConsensusTarget Fair Value

Shared on 10 Dec 25

PLXS: Shares Will Likely Trade Steadily As Execution Offsets Macro Caution

Analysts have modestly increased their Plexus price target to approximately $159 per share. This reflects confidence in the company’s robust execution and long term growth prospects, despite a more cautious stance on the macro environment and valuation.

Shared on 26 Nov 25

PLXS: Shares Will Likely Climb With Confidence In Earnings Momentum

Analysts have modestly increased Plexus’s average price target, citing robust recent results, a positive management outlook, and continued confidence in the company’s growth prospects, with new targets ranging up to $165 from previous levels around $140 to $160. Analyst Commentary Following the latest quarterly report, analysts have provided updated perspectives on Plexus, balancing improved outlooks with some caution regarding future risks.

Shared on 09 Nov 25

PLXS: Shares Will Likely Reflect Mixed Views As Macro Uncertainty Persists

Analysts have slightly raised their price targets for Plexus, citing strong recent results and ongoing confidence in the company's growth prospects. The new targets range from $150 to $165, which is an increase of $10 to $5 from previous estimates.

Shared on 26 Oct 25

Fair value Increased 2.85%

The analyst consensus price target for Plexus has increased by $4.40 to $159.00. This reflects upward revisions in revenue growth expectations and ongoing confidence in management’s execution, even as some firms have issued cautious outlooks recently.

Shared on 08 May 25

Fair value Decreased 2.88%

Shared on 30 Apr 25

Fair value Increased 0.32%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 23 Apr 25

Fair value Decreased 0.76%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 0.15%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 11 Mar 25

Fair value Increased 4.08%

AnalystConsensusTarget has decreased future PE multiple from 24.5x to 21.2x.

AnalystConsensusTarget Fair Value

US$159

3.6% undervalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

7.33%

Electronic Equipment and Components revenue growth rate

0.48%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

8.51%

Calculation

US$211.60m

Earnings '28

x

24.01x

PE Ratio '28

=

US$5.08b

Market Cap '28

US$5.08b

Market Cap '28

/

25.99m

No. shares '28

=

US$195.44

Share Price '28

US$195.44 Share Price '28

Discounted to 2025 @ 8.52% p.a.

=

US$152.93

Fair Value '25